1,049 material Form 8-K filings that 816 companies we cover made with the SEC in May 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
At its May 16, 2025 annual meeting, FormFactor stockholders approved an amendment adding 2,200,000 shares to the 2012 Equity Incentive Plan, and approved all four proposals, including the election of eight directors and ratification of KPMG LLP as auditor for fiscal 2025. The filing reports votes on the plan and directors but no financial results, so it does not indicate a change in company performance.
Stockholders approved adding 2,200,000 shares to the 2012 Equity Incentive Plan (66,359,422 for; 1,373,082 against).
All eight director nominees were elected, including Kevin Brewer, Sheri Rhodes and Brian White, each for a one-year term.
Stockholders approved the non-binding advisory vote on executive compensation (66,732,586 for; 1,003,379 against).
KPMG LLP was ratified as independent registered public accounting firm for fiscal year 2025 (69,363,494 for; 2,906,377 against).
Live Nation Entertainment's board elected Richard Allen Grenell as a director on May 19, 2025. He has not been named to any board committee, and the company says he will receive 102 restricted shares of common stock as a prorated annual non-employee director grant. The filing describes the appointment as a board addition with routine director compensation and indemnification terms, and does not report any financial results.
Board elected Richard Allen Grenell as a director on May 19, 2025; no committee appointments at this time
Grenell will receive 102 shares of restricted common stock, vesting on June 13, 2025
He signed the company's form indemnification agreement for directors (Exhibit 10.1)
Press release issued May 20, 2025 names Chairman Randall Mays welcoming him to the board
Metallus Inc. said Kristopher Westbrooks, its chief financial officer since September 2018, will become president and chief operating officer, and John M. Zaranec III, division CFO at Materion Corporation, will become executive vice president and chief financial officer. Both changes take effect June 16, 2025, and both executives will report to CEO Mike Williams. The filing reports no financial results, so shareholders are seeing a change in the company's top finance and operations roles.
Kristopher R. Westbrooks, age 46, appointed president and chief operating officer effective June 16, 2025, with a $625,000 initial base salary and a 85% target annual award opportunity
John M. Zaranec III, age 44, appointed executive vice president and chief financial officer effective June 16, 2025, with a $450,000 initial base salary and a 65% target annual award opportunity
Zaranec to receive a $100,000 sign-on cash bonus and time-based restricted stock units valued at approximately $500,000 on June 16, 2025
Zaranec's severance agreement provides 2 times benefits if terminated within two years after a change in control and 1.5 times if involuntarily terminated without cause otherwise
Principal Financial Group named Joel Pitz executive vice president and chief financial officer, effective immediately, succeeding Deanna Strable, who became president and CEO in January 2025. Pitz had served as interim CFO since August 2024, so the change formalizes an existing role, and the filing discloses his pay and a family relationship with a company accounting employee.
Pitz was named on May 19, 2025, and the appointment was announced in a news release on May 20, 2025.
Pitz will receive an annual base salary of $552,500, a target annual incentive of 200% of base salary, and a long-term incentive target of $2,348,125 in restricted stock units.
Pitz's spouse, Kristine Pitz, is Director, Accounting, and received $225,034 in base salary and bonuses in 2024; the filing says her pay was approved by the independent Human Resources Committee.
At its May 15, 2025 annual meeting, WEX stockholders elected all 11 board nominees to one-year terms and approved an amendment raising the share pool under its equity plan by about 3.4 million shares, to 4.0 million. Stockholders also approved a non-binding say-on-pay proposal, officer exculpation, and the ratification of Deloitte & Touche as auditor for 2025. The filing reports votes and approvals only, with no financial results.
Equity plan amendment approved: 27,860,387 for and 2,127,447 against, raising shares available to 4.0 million
Say-on-pay proposal approved: 28,594,049 for and 1,385,137 against
Deloitte & Touche LLP ratified as independent auditor for fiscal year ending December 31, 2025: 30,076,743 for and 984,374 against
Board nominees Jim Neary (20,817,546 for, 9,179,600 against) and Jack VanWoerkom (17,774,925 for, 10,431,018 against) received the most opposing votes among directors
At its annual meeting on May 20, 2025, U.S. Physical Therapy shareholders elected all eight director nominees and approved the advisory vote on named executive officer compensation. They also ratified Grant Thornton LLP as the independent registered public accounting firm for 2024. The filing reports routine shareholder votes, with no change in results or financial measures.
Eight directors elected, including Dr. Bernard A. Harris, Jr. (12,422,647 for; 1,175,315 withheld) and Nancy J. Ham (13,500,869 for; 97,093 withheld)
Host Hotels & Resorts, L.P., the operating partnership of Host Hotels & Resorts, Inc., completed a $500 million underwritten public offering of 5.700% Series M senior notes due 2032 on May 20, 2025. The company plans to use the proceeds, together with cash on hand, to redeem all $500 million of its 4.000% Series E senior notes due 2025, so the filing shows a debt refinancing rather than new net borrowing for expansion.
Offering: $500 million of 5.700% Series M senior notes due 2032, completed May 20, 2025
Proceeds, plus cash on hand, to redeem all $500 million of 4.000% Series E senior notes due 2025
Notes pay interest semi-annually; redeemable at a make-whole price before April 16, 2032 (Treasury rate plus 30 basis points)
Indenture requires EBITDA-to-interest coverage of at least 1.5x and total unencumbered assets of at least 150% of unsecured debt
H2O America said its Chief Financial Officer, Andrew F. Walters, will become Chief Executive Officer and join the board on July 1, 2025, when Eric W. Thornburg retires as CEO and president. Thornburg will remain Chair of the board, and shareholders approved the board slate, a non-binding pay vote and the auditor ratification at the May 14, 2025 meeting.
Andrew F. Walters, current CFO and Treasurer, becomes CEO and a board member effective July 1, 2025
Eric W. Thornburg retires as CEO and President effective July 1, 2025 and remains Chair of the Board
Shareholders approved all nine director nominees; Thornburg received 3,338,096 Against votes, the most of any nominee
Shareholders ratified Deloitte & Touche LLP as auditor for fiscal 2025 with 31,311,255 For votes
At its May 15, 2025 annual meeting, Teradata stockholders elected three Class III directors, approved an advisory say-on-pay vote on executive compensation, approved the Amended 2023 Stock Incentive Plan, and ratified PricewaterhouseCoopers LLP as the independent auditor for 2025. The amended plan increases the shares available for issuance by 3,687,000, which affects potential dilution for existing shareholders.
The Amended 2023 Plan adds 3,687,000 shares available for issuance.
Michael P. Gianoni, Todd E. McElhatton and Joanne B. Olsen were elected Class III directors for terms expiring at the 2028 Annual Meeting.
Say-on-pay: 64,232,529 votes for and 12,994,794 against.
PricewaterhouseCoopers LLP ratification: 85,739,834 votes for and 686,584 against.
Toll Brothers reported fiscal second-quarter 2025 results for the period ended April 30, 2025, with net income of $352.4 million, or $3.50 per diluted share, down from $481.6 million, or $4.55, a year earlier. The prior-year figure included a $124.1 million gain from a land sale; excluding that gain, the company's prior-year diluted EPS was $3.38. The company reaffirmed its full-year fiscal 2025 guidance, but net signed contract value fell 11% to $2.60 billion.
Home sales revenues were $2.71 billion, up 2% from the prior-year quarter; 2,899 homes were delivered, up 10%.
Net signed contract value was $2.60 billion, down 11%; contracted homes fell 13% to 2,650.
Home sales gross margin was 26.0%, up from 25.8%; adjusted home sales gross margin fell to 27.5% from 28.2%.
Full-year fiscal 2025 guidance was reaffirmed; the company repurchased about 1.6 million shares for $177.4 million in the quarter.
On May 16, 2025, a U.S. District Court in Delaware ruled in Acadia's favor on both infringement and validity in its '721 formulation patent case over Nuplazid (pimavanserin) against Aurobindo and MSN. The same week, Acadia agreed to a 12-year, two-month lease for about 52,771 square feet in Princeton, New Jersey, and will end its current 502 Carnegie Center lease after the new lease begins.
Court ruling date: May 16, 2025, in the U.S. District Court for the District of Delaware, covering both infringement and validity arguments
Defendants in the patent case: Aurobindo Pharma Limited and its affiliate, and MSN Laboratories Private Ltd. and its affiliate
210 Lease: about 52,771 square feet, term of 12 years and 2 months, commencing no later than January 1, 2026, with first-year payment of $1,899,756
Maximum landlord contribution of $5,277,100 for improvements, with a possible $2,638,550 supplemental contribution repayable with 8.00% interest
Essex Property Trust agreed to replace its $1.2 billion revolving credit facility with a new $1.5 billion facility maturing in January 2030, expected to take effect in July 2025. The company also took on a $300 million unsecured term loan and set up a $750 million commercial paper program, expanding its borrowing capacity and liquidity sources for shareholders.
New revolving facility: $1.5 billion maximum borrowing capacity, maturing January 2030, priced at SOFR plus 0.775%; $535 million was outstanding under the prior facility as of May 20, 2025.
New $300 million unsecured term loan maturing May 20, 2028, with no borrowings outstanding as of May 20, 2025; $150 million is swapped to an all-in rate of 4.1%.
Commercial paper program established with a maximum of $750 million outstanding at any time, backed by the revolving credit facility.
Vestis appointed John Laveck as Vice President and Chief Accounting Officer, effective June 2, 2025, and he will serve as the company's principal accounting officer. The filing describes a routine finance leadership appointment with a $350,000 base salary and equity awards, and it does not report any financial results or change to the company's outlook.
Appointed May 14, 2025; effective June 2, 2025
Base salary of $350,000 with a 35% target bonus under the Management Incentive Bonus Plan
Annual equity award grant value of $135,000; one-time new hire RSU award of $250,000 vesting in thirds over three years
Previously Vice President Accounting Operations at Smurfit Westrock since July 2024 and WestRock since December 2017
At its May 20, 2025 annual meeting, NexPoint Residential Trust stockholders approved the 2025 Long Term Incentive Plan and the other matters on the ballot, including the advisory say-on-pay vote and the KPMG LLP auditor ratification. Director James Dondero received more votes withheld than for, so under the company's majority voting policy he tendered a conditional resignation, and the board must decide within 90 days whether to accept it.
2025 LTIP approved: 18,716,258 votes for, 1,081,993 against and 21,950 abstentions.
James Dondero received 9,787,340 votes for and 10,032,861 withheld; his conditional resignation is pending board action within 90 days of certification.
KPMG LLP ratified as independent registered public accounting firm for 2025: 21,900,535 for and 531,027 against.
25,534,466 shares were entitled to vote, as of the March 24, 2025 record date.
Merit Medical completed its merger with Biolife on May 20, 2025, paying about $120 million in cash on hand, and updated its 2025 guidance to include the business. Net sales guidance was raised to $1.480 billion to $1.501 billion from $1.470 billion to $1.490 billion, while the non-GAAP earnings per share range moved to $3.28 to $3.41 from $3.29 to $3.42. Management said the deal will be slightly dilutive to 2025 non-GAAP profitability.
Purchase price of about $120 million, subject to standard adjustments, paid with available cash; merger effective May 20, 2025
Biolife projected to contribute $10 million to $11 million of revenue from May 20 to December 31, 2025, after about $15 million in revenue for the twelve months ended December 31, 2024
2025 net sales guidance raised to $1.480 billion to $1.501 billion; non-GAAP EPS guidance $3.28 to $3.41 versus prior $3.29 to $3.42
About $7.2 million of non-cash and non-recurring transaction expenses excluded from non-GAAP projections; deal projected to be dilutive to 2025 GAAP net income and EPS
At its May 14, 2025 annual meeting, Enphase stockholders approved an amendment adding 4,000,000 shares to the 2021 Equity Incentive Plan. Director Thurman John Rodgers was re-elected by plurality but did not win a majority of votes cast, which the company attributes mainly to concerns about his service on two other public company boards plus his executive role. The Board's Nominating and Corporate Governance Committee, excluding Mr. Rodgers, will review the matter and report its decision within 90 days of the meeting.
Rodgers received 33,977,145 votes for and 53,852,943 withheld; Steven J. Gomo received 77,174,368 votes for and 10,655,720 withheld.
Stockholders approved the 2021 Plan amendment with 63,891,943 votes for and 23,842,662 against.
Advisory vote on executive compensation: 75,020,823 for and 12,688,703 against.
The Board's decision on Rodgers and its rationale will be disclosed in a Form 8-K within 90 days of May 14, 2025.
Keysight reported second-quarter fiscal 2025 revenue of $1.31 billion, up from $1.22 billion a year earlier, and non-GAAP earnings of $1.70 per share, up from $1.41. The company said revenue and EPS were above the high end of its guidance and raised its full-year growth expectations to the midpoint of its long-term 5-7% target. Separately, director Robert A. Rango retired from the board effective May 15, 2025, for personal reasons.
Q2 revenue was $1.31 billion versus $1.22 billion in Q2 2024; GAAP diluted EPS was $1.49 versus $0.72.
Non-GAAP diluted EPS was $1.70 versus $1.41 a year earlier; free cash flow was $457 million versus $74 million.
Third-quarter fiscal 2025 revenue is expected at $1.305 billion to $1.325 billion, with non-GAAP EPS of $1.63 to $1.69.
Director Robert A. Rango retired from the board effective May 15, 2025, for personal reasons, not due to a disagreement with the company.
Viasat reported fourth quarter and fiscal 2025 results in a shareholder letter filed with the SEC. Quarterly revenue was flat year over year, and the net loss widened to $246 million, including a $169 million ViaSat-3 EMEA ground network write-down, while the full-year net loss improved to $575 million on record revenue of $4.5 billion. The company expects low single-digit revenue growth and flattish Adjusted EBITDA in fiscal 2026.
Q4 FY2025 revenue was $1.1 billion, flat year over year; Q4 net loss was $246 million versus $90 million in Q4 FY2024.
The Q4 loss included a $169 million charge tied to the ViaSat-3 EMEA ground network, of which $104 million was non-cash asset write-downs.
FY2025 revenue was a record $4.5 billion, and the net loss improved to $575 million from the prior year.
For FY2026, the company expects low single-digit revenue growth and flattish Adjusted EBITDA, with capital expenditures of approximately $1.3 billion.
On May 19, 2025, Dorman Products appointed Gregory Bowen, its Vice President, Controller since August 2020, as Vice President, Chief Accounting Officer and principal accounting officer. At the May 16, 2025 annual meeting, shareholders elected all eight director nominees to one-year terms, approved executive pay on an advisory basis, and ratified KPMG LLP as the independent auditor for fiscal 2025.
Bowen's annualized base salary is $375,000, with a target cash incentive of 40% of base salary and a target long-term equity award of 50% of base salary.
Bowen received a one-time restricted stock unit award valued at $100,000, with a grant date on or about June 2, 2025, vesting in thirds over three years.
Executive pay was approved with 27,363,510 votes for and 981,787 against.
KPMG LLP was ratified with 27,816,621 votes for and 1,399,161 against.
ANI Pharmaceuticals filed an investor presentation for the H.C. Wainwright BioConnect conference on May 20, 2025, where CEO Nikhil Lalwani is scheduled to present. The deck restates the revised full-year 2025 guidance issued May 9, 2025, which raised net revenue to $768-793 million from $756-776 million and adjusted EBITDA to $195-205 million from $190-200 million, and describes this as the second guidance raise this year.
Full-year 2025 net revenue guidance is $768-793 million, up from $756-776 million; the deck calls this the second guidance raise in 2025.
Adjusted non-GAAP diluted EPS guidance is $6.27-6.62, up from $6.12-6.49.
Q1 2025 total revenue was $197 million, up 43% year over year; Q1 adjusted non-GAAP EBITDA was $51 million, up 35%.
CEO Nikhil Lalwani will present on May 20, 2025 at the H.C. Wainwright 3rd Annual BioConnect Investor Conference in New York.
Victoria's Secret & Co. adopted a limited-duration shareholder rights plan that expires May 18, 2026, citing substantial share accumulation by BBRC International, which the company says reached about 13% of outstanding shares. Rights are distributed to holders of record on May 29, 2025, and become exercisable only if a person or group acquires 15% or more of the common stock (20% for certain passive investors). The company says the plan is meant to ensure equal treatment and a control premium for all shareholders, and that it was not adopted in response to any specific takeover proposal.
Rights distributed as one per common share held on May 29, 2025, under a Rights Agreement with Equiniti Trust Company, LLC as rights agent
Rights become exercisable if a person or group acquires 15% or more of common stock (20% for certain passive investors); purchase price is $118.00 per one one-thousandth of a Series A Preferred Share
Plan expires May 18, 2026; the company says the Board may consider an earlier termination
Press release cites BBRC's approximately 13% stake and expected access to up to 49.99% of voting stock after the Hart-Scott-Rodino waiting period, expected to end 11:59 p.m. ET on May 21, 2025
At its 2025 Annual Meeting on May 15, 2025, Labcorp shareholders elected all 10 director nominees to terms expiring at the 2026 meeting and approved the 2025 Omnibus Incentive Plan and 2025 Employee Stock Purchase Plan. Shareholders also ratified Deloitte & Touche LLP as the independent auditor for 2025 and approved executive pay in an advisory vote.
Holders of 76,049,607 of 83,668,573 shares on the March 20, 2025 record date were represented, meeting the quorum.
The 2025 Omnibus Incentive Plan received 65,957,167 votes for and 3,916,664 against.
The 2025 Employee Stock Purchase Plan received 69,852,552 votes for and 111,189 against.
Deloitte & Touche LLP was ratified for the year ending December 31, 2025, with 75,696,303 votes for and 297,066 against.
Eagle Materials reported fourth-quarter fiscal 2025 results for the quarter ended March 31, 2025, with revenue of $470.2 million, down 1%, and net earnings of $66.5 million, down 14%. For the full fiscal year, revenue reached a record $2.3 billion, but net earnings fell 3% to $463.4 million while record diluted EPS of $13.77 rose 1%, helped by share repurchases of 1.2 million shares for $298 million.
Q4 revenue of $470.2 million, down 1%; diluted EPS of $2.00, down 11%; adjusted EPS of $2.08, down 7%
Management cited adverse weather in the first two months of calendar 2025 and higher production costs, including a pulled-forward maintenance outage at Texas Lehigh cement facility
Fiscal 2025 record revenue of $2.3 billion; net earnings of $463.4 million, down 3%; record diluted EPS of $13.77, up 1%
Eagle announced a $330 million investment to modernize and expand its Duke, OK Gypsum Wallboard plant, with startup scheduled for the second half of calendar 2027
Schrodinger appointed Richie Jain, previously its senior vice president of strategic finance, as executive vice president and chief financial officer effective May 16, 2025. The company said CFO Geoffrey Porges is leaving the role to pursue other opportunities, and he will stay on as an advisor through June 6, 2025 to support the transition.
Richie Jain appointed CFO and Treasurer effective May 16, 2025; base salary $535,000
Jain eligible for a 2025-only target bonus of up to 55% of annualized base salary, prorated
Company expects to grant Jain an option on up to 18,750 shares and 9,375 restricted stock units
Geoffrey Porges separates from CFO role; remains employed as advisor through June 6, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.